Categories Uncategorized

5 Mistakes to Avoid When Budgeting for a Clinical Trial

Making a concrete budget for clinical trials is always challenging yet sponsors of these clinical trials always try their best to plan adequately for every dollar they will need. However, there are still some unforeseen costs that always emerge. It is therefore always better to budget for the unseen rather than being surprised later.

Most of the established clinical research organizations have carried out many clinical pieces of research hence have the expected experience. Here are some of the mistakes that can be avoided when budgeting for a clinical trial.

Avoid Clinical Trial Delays

A lot of clinical trials always experience delays due to site start-up delays, product availability delays, and enrolment delays. The delays will increase the cost of funding hence creating some gaps in the initial budget. Furthermore, the delays in clinical trials mean more monitoring visits, site selection, and other start-up costs. The delays can be avoided by drawing up a concrete plan, have enough staff, and select the best research site that will meet the need of your trials.

Scope Creep

A reputable contract research organization (“CRO”) will help you in many areas of your clinical trials. However, it would be best if you had a clear scope as the unintentional addition of other ranges that were not in the agreed scope may interfere with your budgeting. A clear scope will help you stick to your budget, hence success in your clinical trials. Some of the unbudgeted ranges between you and your CRO that need to be avoided include:

  • Asking them to support your team with additional monitoring
  • Assist your team with management of data
  • Preparing your squad for inspection by conducting an audit

Improperly Managing Your Travel Expenses

A lot of traveling is always involved in the management of clinical sites, especially where an Investigational Devices Exemption (“IDE”) is required. The traveling costs associated with clinical trials can be significant, especially where a trial master file review is involved. However, some of these costs can be cut by conducting the same trial master file review remotely. It will cut new budgeting hence avoiding additional expenses in your clinical trials.

Staff Layoffs

Staff layoffs are the most frustrating challenges in clinical trials. It is costly to hire and train new staff, which will impact your budget. However, for you to have successful clinical trials, you need to have a competitive crew. You can avoid team layovers by hiring a right CRO with proven records to manage your tests. It will help you save significantly in your budgeting.

Not Partnering with a Budget Friendly Contract Research Organization

Clinical trials always take long; hence having a good partnership with a reliable CRO will protect your budget. Besides, a good CRO will treat your budget as their own; thus, this will have a positive impact on your budgeting. Furthermore, they will also account for every penny spent on their operations and services to help you achieve your clinical trials. Get a good CRO, and you will not make mistakes in your budgeting.

It would be interesting to learn how seasoned sector players like Vivos Therapeutics Inc. navigated their way around the mistakes above during the initial stages before they mastered their craft.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells

Most existing cancer treatments not only attack cancer cells but also adversely impact healthy body cells. The…

1 day ago

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

2 days ago

Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy

Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent…

5 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships

LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and…

5 days ago

California Chooses to Take on Federal Government on Public Health Issues

California, led by Democratic governor Gavin Newsom, has decided to break with the federal positions on public health and…

6 days ago

Earth Science Tech Inc. (ETST) Is Operating a Diversified Portfolio of Businesses in the Pharmaceutical, Healthcare, Telemedicine and Consumer Markets

Earth Science Tech is a holding company that acquires and manages businesses in several markets,…

1 week ago